KAREN WEINSTOCK: Open Payments
NPI 1952908352 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,903 in 84 payments from 16 companies in 2025. Trend: 2023 $4,167 · 2024 $2,551 · 2025 $3,903
Food & beverage: $3,792Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $593 |
| Teva Pharmaceuticals USA, Inc. | 10 | $570 |
| Axsome Therapeutics, Inc. | 6 | $432 |
| ABBVIE INC. | 15 | $421 |
| Vanda Pharmaceuticals Inc. | 7 | $289 |
| Alkermes, Inc. | 5 | $280 |
| Janssen Pharmaceuticals, Inc | 7 | $277 |
| Neurocrine BioSciences, Inc. | 5 | $249 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $196 |
| Collegium Pharmaceutical, Inc. | 2 | $149 |
Products named: CAPLYTA, Auvelity, VRAYLAR, AUSTEDO XR, SPRAVATO, INGREZZA, LYBALVI, FANAPT.
Industry payments across FL — which companies pay providers there.
